Fig. 1From: 18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysisRelation between event-free survival (EFS) and histological tumor type (a), tumor grade (b), progesterone receptor (PR) expression (c) and pathology findings after neoadjuvant chemotherapy (d), in 143 patients with ER+/HER2- breast cancer. IDC invasive ductal carcinoma, ILC invasive lobular carcinoma, pCR pathological complete responseBack to article page